SCHEMBL16408484

SCHEMBL16408484

O=C(O)c1cccc(S(=O)(=O)C2CCCCCC2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 5/20 0.66
KMO O15229 1/20 0.54
MAPT P10636 1/20 0.54
IL1RN P18510 1/20 0.54
ALDH1A1 P00352 3/20 0.51
AKR1C1 Q04828 2/20 0.51
EPHX2 P34913 1/20 0.51
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
POLB P06746 1/20 0.49
LMNA P02545 1/20 0.48
F2 P00734 1/20 0.48
PRSS1 P07477 1/20 0.48
PRSS2 P07478 1/20 0.48
PRSS3 P35030 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
HTT P42858 1/20 0.47
GFER P55789 1/20 0.46
APEX1 P27695 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1000570 1.00 AKR1C3 (0.66) AKR1C3KMOMAPTIL1RNALDH1A1
SCHEMBL2566255 0.98 AKR1C3 (0.68) AKR1C3KMOMAPTIL1RNALDH1A1
SCHEMBL30921570 0.98 AKR1C3 (0.68) AKR1C3KMOMAPTIL1RNALDH1A1
SCHEMBL31192547 0.92 AKR1C3 (0.71) AKR1C3KMOMAPTIL1RNALDH1A1
SCHEMBL21225183 0.92 AKR1C3 (0.71) AKR1C3KMOMAPTIL1RNALDH1A1
SCHEMBL26144972 0.84 AKR1C3 (0.55) AKR1C3KMOMAPTIL1RNALDH1A1
SCHEMBL29503132 0.84 GAA (0.55) AKR1C3ALDH1A1KMT2ALMNA
SCHEMBL18383378 0.82 AKR1C3 (0.48) AKR1C3ALDH1A1EPHX2KMT2ALMNA
Hydrochloric Acid SCHEMBL5130887 0.82 AKR1C3 (0.56) AKR1C3KMOMAPTIL1RNALDH1A1
SCHEMBL16903002 0.82 SMN1; SMN2 (0.62) MAPTALDH1A1KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150025235-A1 Benzamide Compounds and Related Methods of Use NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150025235-A1 Benzamide Compounds and Related Methods of Use SIRT2, SIRT1, SIRT3 AKR1C3 3742/4885KMO 989/4885MAPT 248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.